APMD — Apnimed, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1745648 ·
Last close
$17.80
Market Cap
$741.03M
52W High
$35.29
52W Low
$13.88
ADV30
388,304
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 12,080,000 | 10,870,000 | -11,704,000 | 125,935,000 | 195,456,000 | 172,804,000 | 371,637,000 |
| Mar 2026 | 84,814,000 | 82,654,000 | 68,044,000 | 70,373,000 | 342,634,000 | 328,884,000 | 85,044,000 |
| Jun 2025 | 17,110,000 | 15,386,000 | -5,936,000 | -69,474,000 | — | — | — |
| Mar 2025 | 3,131,000 | 1,814,000 | -27,112,000 | -28,646,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,747,000
Investing CF
—
Financing CF
$85,468,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.87
As of
2026-09-13
Balance + Analyst (yfinance extras)
Retained Earnings
$-203,690,000
Inventory
—
Receivables
$690,000
ST Investments
—
EBIT TTM
$23,292,000
Pretax Income TTM
$164,178,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$115,120,000
EBITDA
$35,897,000
Free Cash Flow
—
Enterprise Value
$929,897,024
Total Cash
$172,804,000
Total Debt
$80,348,000
Shares Out
41,630,779
Trailing EPS
$7.22
Book Value
$-36.69
ROE
—
ROA
—
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 38,467,000 | -53,818,000 | -932,000 | 72,873,000 | 445,656,000 | -372,783,000 | -77,832,000 |
| Dec 2024 | 8,012,000 | -114,234,000 | -111,305,000 | 109,223,000 | 357,838,000 | -248,615,000 | -110,209,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$195,456,000
Forward EPS
$-3.98
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PAHC | PHIBRO ANIMAL HEALTH CORP | $737.01M | $34.92 | — |
| OBX | Obsidian Therapeutics, Inc. | $745.61M | $12.07 | — |
| IVEVF | Inventiva S.A. | $751.18M | $3.18 | — |
| IVA | Inventiva S.A. | $760.63M | $3.22 | — |
| SGMT | Sagimet Biosciences Inc. | $702.97M | $9.85 | — |
News headlines (Yahoo Finance, 1h cache)
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-16 13:00 · Yahoo
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-11-05 21:05 · Yahoo
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
2026-10-12 20:05 · Yahoo
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-09-08 20:39 · Yahoo
BofA makes bullish call on newly public biotech stock
2026-08-29 01:03 · Yahoo
Apnimed shares surge on bullish BofA initiation
2026-08-25 16:12 · Yahoo
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
2026-10-15 07:30 · Yahoo
Bank of America Puts These 2 Under-the-Radar IPO Stocks on Its Buy List
2026-10-06 17:58 · Yahoo
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-22 17:39 · Yahoo
Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-26 15:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.